Abivax (ABVX) announces the pricing of its previously announced underwritten public offering of 10,156,000 American Depositary Shares, each representing one ordinary share of the company, in the United States at an offering price of $64.00 per ADS. Leerink Partners, Piper Sandler & Co. and Guggenheim Securities are acting as joint bookrunning managers for the offering. LifeSci Capital is acting as lead manager, with BTIG and Van Lanschot Kempen acting as co-managers for the offering.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABVX: